The biological basis of autism spectrum disorders: understanding causation and treatment by clinical geneticists

• Autorzy: Geier D.A. , Kern J. K. , Geier M. R.
• Języki publikacji: EN

Abstrakty

EN

Autism spectrum disorders (ASDs), also known as pervasive developmental disorders (PDD), are a behaviorally defined group of neurodevelopmental disorders that are usually diagnosed in early childhood. ASDs disproportionately affect male children. Mercury (Hg), a heavy metal, is widespread and persistent in the environment. Mercury is a ubiquitous source of danger in fish, drugs, fungicides/herbicides, dental fillings, thermometers, and many other products. Elevated Hg concentrations may remain in the brain from several years to decades following exposure. This is important because investigators have long recognized that Hg is a neurodevelopmental poison; it can cause problems in neuronal cell migration and division, and can ultimately cause cell degeneration and death. Case-reports of patients have described developmental regressions with ASD symptoms following fetal and/or early childhood Hg exposure, and epidemiological studies have linked exposure to Hg with an elevated risk of a patient being diagnosed with an ASD. Immune, sensory, neurological, motor, and behavioral dysfunctions similar to traits defining or associated with ASDs were reported following Hg intoxication with similarities extending to neuroanatomy, neurotransmitters, and biochemistry. The sexual dimorphism of ASDs may result from synergistic neurotoxicity caused by the interaction of testosterone and Hg; in contrast, estrogen is protective, mitigating the toxicity of Hg. Mercury exposure may significantly increase androgen levels, and as a result, patients diagnosed with an ASD may significantly benefit from anti-androgen therapy. Finally, the clinical geneticist has a wealth of biomarkers to evaluate and treat patients diagnosed with an ASD.

• Wydawca: -
• Czasopismo: Acta Neurobiologiae Experimentalis
• Rocznik: 2010
• Tom: 70
• Numer: 2
• Opis fizyczny: p.209-226,ref.

Twórcy

autor

Geier D.A.

• The Institute of Chronic Illnesses, Inc., Silver Spring, Maryland, USA
• CoMeD, Inc., Silver Spring, Maryland, USA

autor

Kern J. K.

• Genetic Consultants of Dallas, Allen, Texas, USA
• University of Texas Southwestern Medical Center, Dallas, Texas, USA

autor

Geier M. R.

• ASD Centers, LLC, Silver Spring, Maryland, USA

Bibliografia

• Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, Zappia I, Newmark S, Gehn E, Rubin RA, Mitchell K, Bradstreet J, El-Dahr JM (2009) The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol 2009: 532640.
• Adams JB, Romdalvik J, Ramanujam VM, Legator MS (2007) Mercury, lead, and zinc in baby teeth of children with autism versus controls. J Toxicol Environ Health A 70: 1046-1051.
• Adams JB, Romdalvik J, Levine KE, Hu LW (2008) Mercury in first-cut baby hair of children with autism versus typically-developing children. Toxicol Environ Chem 90: 739-753.
• Ariano P, Erriquez J, Gilardino A, Ferraro M, Lovisolo D, Distasi C (2006) Calcium signals and the in vitro migra­tion of chick ciliary ganglion cells. Cell Calcium 40: 63-71.
• Austin D (2008) An epidemiological analysis of the 'autism as mercury poisoning' hypothesis. Int J Risk Saf Med 20: 135-142.
• Austin DW, Shandley K (2008) An investigation of porphy- rinuia in Australian children with autism. J Toxicol Environ Health A 71: 1349-1351.
• Barregard L, Lindstedt G, Schutz A, Sallsten G (1994) Endocrine function in mercury exposed chloralkali work­ers. Occup Environ Med 51: 536-540.
• Belson MG, Schier JG, Patel MM (2005) Case definitions for chemical poisoning. MMWR Recomm Rep 54: 1-24.
• Bigham M, Copes R (2005) Thimerosal in vaccines: balanc­ing the risk of adverse effects with the risk of vaccine- preventable disease. Drug Saf 28: 89-101.
• Blaxill MF (2004) What's going on? The question of time trends in autism. Public Health Rep 119: 536-551.
• Bolte S, Poustka F (2002) The relation between general cognitive level and adaptive behavior domains in indi­viduals with autism with and without co-morbid mental retardation. Child Psychiatry Hum Dev 33: 165-172.
• Bourdineaud JP, Bellance N, Benard G, Brethes D, Fujimura M, Gonzalez P, Marighetto A, Maury-Brachet R, Mormede C, Pedron V, Philippin JN, Rossignol R, Rostene W, Sawada M, Laclau M (2008) Feeding mice with diets containing mercury-contaminated fish flesh from French Guiana: a model for the mercurial intoxication of the Wayana Amerindians. Environ Health 7: 53.
• Bradstreet J, Geier DA, Kartzinel JJ, Adams JB, Geier MR (2003) A case-control study of mercury burden in chil­dren with autistic spectrum disorders. J Am Phys Surg 8: 76-79.
• Branch DR (2009) Gender-selective toxicity of Thimerosal. Exp Toxicol Pathol 61: 133-136.
• Bryan KJ, Mudd JC, Richardson SL, Chang J, Lee HG, Zhu X, Smith MA, Casadesus G (2010) Down-regulation of serum gonadotropins is as effective as estrogen replace­ment at improving menopause-associated cognitive defi­cits. J Neurochem 112: 870-881.
• Burbacher TM, Sackett GP, Mottet NK (1990) Methylmercury effects on the social behavior of Macaca fascicularis infants. Neurotoxicol Teratol 12: 65-71.
• Burbacher TM, Shen DD, Liberato N, Grant KS, Cernichiari E, Clarkson T (2005) Comparison of blood and brain mercury levels in infant monkeys exposed to methylmer- cury or vaccines containing Thimerosal. Environ Health Perspect 113: 1015-1021.
• Burke K, Cheng Y, Li B, Petrov A, Joshi P, Berman RF, Reuhl KR, DiCicco-Bloom E (2006) Methylmercury elicits rapid inhibition of cell proliferation in the develop­ing brain and decreases cell cycle regulator, cyclin E. Neurotoxicology 27: 970-981.
• Centers for Disease Control and Prevention (2004) Blood mercury levels in young children and childbearing-aged women-United States, 1999-2002. MMWR Morb Mortal Wkly Rep 53: 1018-1020.
• Centers for Disease Control and Prevention (2007) Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, 13 sites, United States, 2002. MMWR Surveill Summ 56: 12-28.
• Chauhan A, Chauhan V (2006) Oxidative stress in autism. Pathophysiology 13: 171-181.
• Chrysochoou C, Rutishauser C, Rauber-Luthy C, Neuhaus T, Boltshauser E, Superti-Furga A (2003) An 11-month- old boy with psychomotor regression and auto-aggressive behavior. Eur J Pediatr 162: 559-561.
• Cheek DB, Hetzel BS, Hine DC (1951) Evidence of adrenal cortical function in pink disease. Med J Aust 2: 6-8.
• Clarkson TW, Nordberg GF, Sager PR (1985) Reproductive and developmental toxicity of metals. Scand J Work Environ Health 11: 145-154.
• Collaborative on Health and the Environment's Learning and Developmental Disabilities Initiative (2008) LDDI Scientific consensus statement on environmental agents associated with neurodevelopmental disorders. Seattle, WA
• Corbett SJ, Poon CSC (2008) Toxic levels of mercury in Chinese infants eating fish congee. Med J Aust 188: 59-60.
• Counter SA, Buchanan LH, Ortega F, Laurell G (2002) Elevated blood mercury and neuro-otological observa­tions in children of the Ecuadorian gold mines. J Toxicol Environ Health A 65: 149-163.
• de Bruin EI, Verheij F, Wiegman T, Ferdinand RF (2006) Differences in finger length ratio between males with autism, pervasive developmental disorder-not otherwise specified, ADHD, and anxiety disorders. Dev Med Child Neurol 48: 962-965.
• DeSoto MC, Hitlan RT (2007) Blood levels of mercury are related to diagnosis of autism: a reanalysis of an impor­tant data set. J Child Neurol 22: 1308-1311.
• Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M (2008) How environmental and genetic factors combine to cause autism: A redox/mythylation hypothe­sis. Neurotoxicology 29: 190-201.
• Dorn LD, Hitt SF, Rotenstein D (1999) Biopsychological and cognitive differences in children with premature vs. on-time adrenarche. Arch Pediatr Adolesc Med 153: 137-146.
• Falluel-Morel A, Sokolowski K, Sisti HM, Zhou X, Shors TJ, Dicicco-Bloom E (2007) Developmental mercury exposure elicits acute hippocampal cell death, reductions in neurogenesis, and severe learning deficits during puberty. J Neurochem 103: 1968-1981.
• Faustman EM, Silbernagel SM, Fenske RA, Burbacher TM, Ponce RA (2000) Mechanisms underlying children's sus­ceptibility to environmental toxicants. Environ Health Perspect 108(Suppl 1): 13-21.
• Fido A, Al-Saad S (2005) Toxic trace elements in the hair of children with autism. Autism 9: 290-298.
• Fischer C, Fredriksson A, Eriksson P (2008) Neonatal co- exposure to low doses of an ortho-PCB (PCB 153) and methyl mercury exacerbate defective developmental neu- robehavior in mice. Toxicology 244: 157-165.
• Freeman HC, Sangalang GB (1977) A study of the effects of methyl mercury, cadmium, arsenic, selenium, and a PCB, (Aroclor 1254) on adrenal and testicular steroidogeneses in vitro, by the gray seal Halichoerus grypus. Arch Environ Contam Toxicol 5: 369-383.
• Gallagher C, Goodman M (2008) Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. Toxicol Environ Chem 90: 997-1008.
• Geier DA, Geier MR (2006a) A clinical and laboratory evaluation of methionine cycle-transsulfuration and androgen pathway markers in children with autistic disor­ders. Horm Res 66: 182-188.
• Geier DA, Geier MR (2006b) A meta-analysis epidemio- logical assessment of neurodevelopmental disorders fol­lowing vaccines administered from 1994 through 2000 in the United States. Neuro Endocrinol Lett 27: 401-413.
• Geier DA, Geier MR (2006c) A prospective assessment of porphyrins in autistic disorders: a potential marker for heavy metal exposure. Neurotox Res 10: 57-64.
• Geier DA, Sykes LK, Geier MR (2007a) A review of Thimerosal (Merthiolate) and its ethylmercury break­down product: specific historical considerations regard­ing safety and effectiveness. J Toxicol Environ Health B Crit Rev 10: 575-596.
• Geier DA, Geier MR (2007b) A case series of children with apparent mercury toxic encephalopathies manifest­ing with clinical symptoms of regressive autistic disor­ders. J Toxicol Environ Health A 70: 837-851.
• Geier DA, Geier MR (2007c) A prospective assessment of androgen levels in patients with autistic spectrum disor­ders: biochemical underpinnings and suggested therapies. Neuro Endocrinol Lett 28: 565-573.
• Geier DA, Geier MR (2007d) A prospective study of mer­cury toxicity biomarkers in autistic spectrum disorders. J Toxicol Environ Health A 70: 1723-1730.
• Geier DA, Geier MR (2008a) Autism spectrum disorder-as­sociated biomarkers for case evaluation and management by clinical genetics. Expert Rev Mol Diagn 8: 671-674.
• Geier DA, King PG, Sykes LK, Geier MR (2008b) A com­prehensive review of mercury provoked autism. Indian J Med Res 128: 383-411.
• Geier DA, Mumper E, Gladfelter B, Coleman L, Geier MR (2008c) Neurodevelopmental disorders, maternal Rh-negativity, and Rho(D) immune globulins: a multi­center assessment. Neuro Endocrinol Lett 29: 272-280.
• Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR (2009a) A prospective study of transsulfuration bio­markers in autistic disorders. Neurochem Res 34: 386-393.
• Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, Geier MR (2009b) Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci 280: 101-108.
• Geier DA, Kern JK, Geier MR (2009c) A prospective blind­ed evaluation of urinary porphyrins verses the clinical severity of autism spectrum disorders J Toxicol Environ Health A 72: 1585-1591.
• Geier DA, Kern JK, Geier MR (2009d) A prospective study of oxidative stress biomarkers in autistic disorders. Electron J Appl Psychol 5: 2-10.
• Geier DA, Kern JK, Geier MR (2009e) A prospective study of prenatal mercury exposure from maternal dental amal­gams and autism severity. Acta Neurobiol Exp (Wars) 69: 189-197.
• Geier DA, King PG, Geier MR (2009f) Mitochondrial dys­function, impaired oxidative-reduction activity, degenera­tion, and death in human neuronal and fetal cells induced by low-level exposure to Thimerosal and other metal compounds. Toxicol Environ Chem 91: 735-749.
• Geier DA, Kern JK Geier MR (in press) Blood mercury levels in autism spectrum disorder: is there a threshold level? Acta Neurobiol Exp (Wars).
• Geier DA, Young HA, Geier MR (2010) Thimerosal exposure and increasing trends of premature puberty in the Vaccine Safety Datalink. Indian J Med Res 131: 500-507.
• Geier MR, Geier DA (2005) The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Med Hypotheses 64: 946-954.
• Gerstenberger SL, Heimler I, Smies R, Hutz RJ, Dasmahapatra AK, Tripoli V, Dellinger JA (2000) Minimal endocrine alterations in rodents after consumption of lake trout (Salvelinus namaycush). Arch Environ Contam Toxicol 38: 371-376.
• Giammanco M, Tabacchi G, Giammanco S, Di Majo D, La Guardia M (2005) Testosterone and aggressiveness. Med Sci Monit 11: RA136-RA145.
• Grandjean P, Weihe P, White RF, Debesa F (1998) Cognitive performance of children prenatally exposed to "safe" levels of methylmercury. Environ Res 77: 165-172.
• Haley BE (2005) Mercury toxicity: genetic susceptibility and synergistic effects. Med Ver 2: 535-542.
• Herdman ML, Marcelo A, Huang Y, Niles RM, Dhar S, Kiningham KK (2006) Thimerosal induces apoptosis in a neuroblastoma model via the cJun N-terminal kinase pathway. Toxicol Sci 92: 246-253.
• Hertz-Picciotto I, Delwiche L (2009) The rise in autism and the role of age at diagnosis. Epidemiology 20: 84-90.
• Holmes AS, Blaxill MF, Haley BE (2003) Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 22: 277-285.
• Hornig M, Chian D, Lipkin WI (2004) Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9: 833-845.
• Humphrey ML, Cole MP, Pendergrass JC, Kiningham KK (2005) Mitochondrial mediated Thimerosal-induced apoptosis in a human neuroblastoma cell line (SK-N-SH). Neurotoxicology 26: 407-416.
• James SJ, Rose S, Melnyk S, Jernigan S, Blossom S, Pavliv O, Gaylor DW (2009) Cellular and mitochondrial gluta­thione redox imbalance in lymphoblastoid cells derived from children with autism. FASEB J 23: 2374-2783.
• James SJ, Slikker W 3rd, Melnyk S, New E, Pogribna M, Jernigan S (2005) Thimerosal neurotoxicity is associated with glutathione depletion: protection with glutathione precursors. Neurotoxicology 26: 1-8.
• Kent L, Emerton J, Bhadravathi V, Weisblatt E, Pasco G, Willatt LR, McMahon R, Yates JR (2008) X-linked ich- thyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism, and social communication deficits. J Med Genet 45: 519-524.
• Kim MS, Shigenaga J, Moser A, Grunfeld C, Feingold KR (2004) Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response. Am J Physiol Endocrinol Metab 287: 731-738.
• Laurente J, Remuzgo F, Avalos B, Chiquinta J, Ponce B, Avendano R, Maya L (2007) Neurotoxic effects of thime- rosal at vaccines doses on the encephalon and develop­ment in 7 days-old hamsters. Ann Fac Med (Lima, Peru) 68: 222-237.
• Lawton M, Iqbal M, Kontovraki M, Lloyd Mills C, Hargreaves AJ (2007) Reduced tubulin tyrosination as an early marker of mercury toxicity in differentiating N2a cells. Toxicol In Vitro 21: 1258-1261.
• Lederman SA, Jones RL, Caldwell KL, Rauh V, Sheets SE, Tang D, Viswanathan S, Becker M, Stein JL, Wang RY, Perera FP (2008) Relation between cord blood mercury levels and early child development in a World Trade Center cohort. Environ Health Perspect 116: 1085-1091.
• Loosen PT, Purdon SE, Pavlou SN (1994) Effects on behav­ior of modulation of gonadal function in men with gonadotropin-releasing hormone antagonists. Am J Psychiatry 151: 271-273.
• Lopez-Hurtado E, Prieto JJ (2008) A microscopic study of language-related cortex in autism. Am J Biochem Biotech 4: 130-145.
• Lutchmaya S, Baron-Cohen S, Raggatt P, Knickmeyer R, Manning JT (2004) 2nd to 4th digit ratios, fetal testosterone and estradiol. Early Hum Dev 77: 23-28.
• Manning JT, Baron-Cohen S, Wheelwright S, Sanders G (2001) The 2nd to 4th digit ratio and autism. Dev Med Child Neurol 43: 160-164.
• Marques RC, Bernardi JV, Dorea JG, Bastos WR, Malm O (2008) Principal component analysis and discrimination of variables associated with pre- and post-natal exposure to mercury. Int J Hyg Environ Health 211: 606-614.
• Marques RC, Dorea JG, Fonseca MF, Bastos WR, Malm O (2007) Hair mercury in breast-fed infants exposed to Thimerosal-preserved vaccines. Eur J Pediatr 166: 935­941.
• Mathias JR, Clench MH, Abell TL, Kock KL, Lehman G, Robinson M, Rothstein R, Snape WJ (1998) Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci 43: 1347-1355.
• Minami T, Miyata E, Sakamoto Y, Yamazaki H, Ichida S (2010) Induction of metallothionein in mouse cerebellum and cerebrum with low-dose Thimerosal injection. Cell Biol Toxicol 26: 143-152.
• Montgomery KS, Mackey J, Thuett K, Ginestra S, Bizon JL, Abbott LC (2008) Chronic low-dose prenatal exposure to methylmercury impairs motor and mnemonic function in adult C57/B6 mice. Behav Brain Res 191: 55-61.
• Nataf R, Skorupka C, Amet L, Lam A, Springbett A, Lathe R (2006) Porphyrinuria in childhood autistic disorder: implications for environmental toxicity. Toxicol Appl Pharmacol 214: 99-108.
• Nataf R, Skorupka C, Lam A, Springbett A, Lathe R (2008) Porphyrinuria in childhood autistic disorder is not associ­ated with urinary creatinine deficiency. Pediatr Int 50: 528-532.
• Nelson BK (1991) Evidence for behavioral teratogenicity in humans. J Appl Toxicol 11: 33-37.
• Olczak M, Duszczyk M, Mierzejewski P, Majewska MD (2009) Neonatal administration of a vaccine preservative, Thimerosal, produces lasting impairment of nociception and apparent activation of opioid system in rats. Brain Res 1301: 143-151.
• Opitz H, Schweinsberg F, Grossmann T, Wendt-Gallitelli MF, Meyermann R (1996) Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure. Clin Neuropathol 15: 139-144.
• Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C (2006) Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place 12: 203-209.
• Palmer RF, Blanchard S, Wood R (2009) Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place 15: 18-24.
• Prudova A, Albin M, Bauman Z, Lin A, Vitvitsky V, Banerjee R (2007) Testosterone regulation of homocysteine metab­olism modulates redox status in human prostate cancer cells. Antioxid Redox Signal 9: 1875-1881.
• Parran DK, Barker A, Ehrich M (2005) Effects of Thimerosal on NGF signal transduction and cell death in neuroblas­toma cells. Toxicol Sci 86: 132-140.
• Pichichero ME, Gentile A, Giglio N, Umido V, Clarkson T, Cernichiari E, Zareba G, Gotelli C, Gotelli M, Yan L, Treanor J (2008) Mercury levels in newborns and infants after receipt of Thimerosal-containing vaccines. Pediatrics 121: e208-e214.
• Redwood L, Bernard S, Brown D (2001) Predicted mercury concentrations in hair from infant immunizations: cause for concern. Neurotoxicology 22: 691-697.
• Rury J (2006) Links between environmental mercury, spe­cial education, and autism in Louisiana (dissertation). Baton Rouge (LA): Louisiana State University.
• Ryan RA, Carroll J (1976) Studies on a 3ß-hydroxysteroid sulphotransferase from rat liver. Biochim Biophys Act 429: 391-401.
• Sajdel-Sulkowska EM, Lipinski B, Windom H, Audhya T, McGinnis W (2008) Oxidative stress in autism: elevated cerebellar 3-nitrotyrosine levels. Am J Biochem Biotech 4: 73-84.
• Schweikert C, Li Y, Dayya D, Yens D, Torents M, Hsu F (2009) Analysis of autism prevalence and neurotoxins using combinatorial fusion and association rule mining. Ninth IEEE Computer Science International Conference on Bioinformatics and Bioengineering, 400-404.
• Stajich GV, Lopez GP, Harry SW, Sexson WR (2000) Iatrogenic exposure to mercury after hepatitis B vaccina­tion in preterm infants. J Pediatr 136: 679-681.
• Strous RD, Golubchik P, Maayan R, Mozes T, Tuati-Werner D, Weizman A, Spivak B (2005) Lowered DHEA-S plasma levels in adult individuals with autistic disorder. Eur Neuropsychopharmacol 15: 305-309
• Sugita M (1978) The biological half-time of heavy metals. The existence of a third, "slowest" component. Int Arch Occup Environ Health 41: 25-40.
• Sweeten TL, Bowyer SL, Posey DJ, Halberstadt CM, McDougle CJ (2003) Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112: e420.
• Takahashi T, Kimura T, Sato Y, Shiraki H, Ukita T (1971) Time-dependent distribution of 203Hg-mercury compounds in rat and monkey as studied by whole body autoradiog- raphy. J Hyg Chem 17: 93-107.
• Thompson WW, Praice C, Goodson B, Shay DK, Benson P, Hinrichsen VL, Lewis E, Eriksen E, Ray P, Marcy SM, Dunn J, Jackson LA, Lieu TA, Black S, Stewart G, Weintraub ES, Davis RL, DeStefano F; Vaccine Safety Datalink Team (2007) Early Thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357: 1281-1292.
• Toimela T, Tahti H (2004) Mitochondrial viability and apoptosis induced by aluminum, mercuric mercury and methylmercury in cell lines of neural origin. Arch Toxicol 78: 565-574.
• Tordjman S, Ferrari P, Sulmont V, Duyme M, Roubertoux P (1997) Androgenic activity in autism. Am J Psychiatry 154: 1626-1627.
• Tozzi AE, Bisiacchi P, Tarantino V, De Mei B, D'Elia L, Chiarotti F, Salmaso S (2009) Neuropsychological perfor­mance 10 years after immunization in infancy with Thimerosal-containing vaccines. Pediatrics 123: 475-482.
• Umathe SN, Bhutada PS, Dixit PV, Jain NS (2008a) Leuprolide: a luteinizing hormone releasing hormone agonist attenuates ethanol withdrawal syndrome and eth- anol-induced locomotor sensitization in mice. Neuropeptides 42: 345-353.
• Umathe SN, Bhutada PS, Jain NS, Dixit PV, Wanjari MM (2008b) Effects of central administration of gonadotro- pin-releasing hormone agonists and antagonist on elevat­ed plus-maze and social interaction behavior in rats. Behav Pharmacol 19: 308-316.
• Umathe SN, Bhutada PS, Jain NS, Shukla NR, Mundhada YR, Dixit PV (2008c) Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect ofcorticotrophin-releasing hormone in mice. Neuropeptides 42: 399-410.
• Umathe SN, Dixit PV, Wanjari MM, Ullewar MP (2008d) Leuprolide-a GnRH agonist-prevents restraint stress-induced immunosuppression via sex-steroid independent peripheral mechanism in mice. Int Immunopharmacol 8: 71-79.
• Vahter M, Akesson A, Liden C, Ceccatelli S, Berglund M (2007) Gender differences in the disposition and toxicity of metals. Environ Res 104: 85-95.
• Veltman JC, Maines MD (1986) Alternations of heme, cyto­chrome P-450, and steroid metabolism by mercury in rat adrenal. Arch Biochem Biophys 248: 467-478.
• Verstraeten T, Davis RL, DeStefano F, Lieu TA, Rhodes PH, Black SB, Shinefield H, Chen RT; Vaccine Safety Datalink Team (2003) Safety of Thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases. Pediatrics 112: 1039-1048.
• Waly M, Olteanu H, Banerjee R, Choi SW, Mason JB, Parker BS, Sukumar S, Shim S, Sharma A, Benzecry JM, Power-Carnitsky VA, Deth RC (2004) Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and Thimerosal. Mol Psychiatry 9: 358-370.
• White JF (2003) Intestinal pathophysiology in autism. Exp Biol Med 228: 639-649.
• Windham GC, Zhang L, Gunier R, Croen LA, Grether JK (2006) Autism spectrum disorders in relation to distribu­tion of hazardous air pollutants in the San Francisco Bay area. Environ Health Perspect 114: 1438-1444.
• Xu F, Suiko M, Sakakibara Y, Pai TG, Liu MC (2002) Regulatory effects of divalent metal cations on human cytosolic sulfotransferases. J Biochem 132: 457-462.
• Yel L, Brown LE, Su K, Gollapudi S, Gupta S (2005) Thimerosal induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from mitochondria. Int J Mol Med 16: 971-977.
• Yochum CL, Wagner GC (2009) Autism and Parkinson's disease: animal models and a common etiological mecha­nism. Chin J Physiol 52: 236-249.
• Young HA, Geier DA, Geier MR (2008) Thimerosal expo­sure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J Neurol Sci 271: 110-118.

Uwagi

PL

Rekord w opracowaniu